Chardan Capital Markets Initiates Research Coverage of Adeona
Adeona Pharmaceuticals Inc. (NYSE: AEN), announced Thursday that Chardan Capital Markets initiated independent equity research coverage of the company with a "Buy" rating and a 12-month price target of $1 per share.
